Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis.
Amir A RazmjouJenny BrookDavid ElashoffGurjit KaeleySoo ChoiTanaz KermaniVeena K RanganathPublished in: BMC rheumatology (2020)
ClinicalTrials.gov NCT02321930 (registered 12/22/2014).